Discontinuation report LOPRESOR SR 100MG
Report ID | 128056 |
Drug Identification Number | 00658855 |
Brand name | LOPRESOR SR 100MG |
Common or Proper name | LOPRESOR SR 100MG 250'S |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | METOPROLOL TARTRATE |
Strength(s) | 100MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 250'S |
ATC code | C07AB |
ATC description | BETA BLOCKING AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-11-16 |
Actual discontinuation date | 2020-11-19 |
Remaining supply date | 2020-11-10 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-11-06 | English | Compare |
v2 | 2020-11-06 | French | Compare |
v3 | 2020-11-13 | English | Compare |
v4 | 2020-11-13 | French | Compare |
v5 | 2020-12-08 | English | Compare |
v6 | 2020-12-08 | French | Compare |
v7 | 2020-12-08 | French | Compare |
v8 | 2020-12-08 | French | Compare |
Showing 1 to 8 of 8